[HTML][HTML] The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - Metabolites, 2021 - mdpi.com
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
[PDF][PDF] The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study. Metabolites 2021, 11, 379
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - 2021 - academia.edu
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study
B Molloy, L Mullin, A King, LA Gethings… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study
B Molloy, L Mullin, A King, LA Gethings… - …, 2021 - search.proquest.com
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
[HTML][HTML] The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - Metabolites, 2021 - ncbi.nlm.nih.gov
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - 2021 - agris.fao.org
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study.
B Molloy, L Mullin, A King, LA Gethings… - Metabolites (2218 …, 2021 - search.ebscohost.com
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study.
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - Metabolites, 2021 - europepmc.org
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study.
B Molloy, L Mullin, A King, LA Gethings, RS Plumb… - Metabolites, 2021 - europepmc.org
The effects of intravenous gefitinib (10 mg/kg), an anilinoquinazoline thymidylate kinase
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …
inhibitor (TKI), selective for the epidermal growth factor receptor (EGFR), on the urinary …